Time Course of the Interaction between Tadalafil and Nitrates

Journal of the American College of Cardiology

Volumn 42, Issue 10, 2003, Pages 1855-1860

  Kloner, Robert A ^a,f   Hutter, Adolph M ^b   Emmick, Jeffrey T ^c   Mitchell, Malcolm I ^d   Denne, Jonathan ^a,c   Jackson, Graham ^e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d Erl Wood Manor   (United Kingdom)

^e GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^f GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; TADALAFIL;

ADULT; AGED; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSPEPSIA; FLUSHING; HEADACHE; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUS ARREST; SYSTOLIC BLOOD PRESSURE; VERTIGO;

EID: 0242552045     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.09.023     Document Type: Article

References (11)

1. Webb DJ, Muirhead GJ, Wulff M, et al. Sildenafil citrate potentiates the hypertensive effects of nitric oxide donor drugs in male patients with stable angina. J Am Coll Cardiol 2000;36:25-31.
2. Webb DJ, Freestone S, Allen MJ, et al. Sildenafil citrate and blood pressure lowering drugs: results of drug interaction studies with an organic nitrate and calcium antagonist. Am J Cardiol 1999;83:21C-8C.
3. Emmick JT, Stuewe SR, Mitchell M. Overview of the cardiovascular effects of tadalafil. Eur Heart J 2002;4:H32-47.
4. Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998;338:1397-404.
5. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995;75:725-48.
6. Kloner RA. Sex and the patient with cardiovascular risk factors: focus on sildenafil. Am J Med 2000;109:13S-21S.
7. Cheitlin MD, Hutter AM Jr., Brindis RG, et al. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. J Am Coll Cardiol 1999;33:273-82.
8. Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 2002;168:1332-6.
9. Brown H, Prescott R. Cross over trials. In: Applied Mixed Models in Medicine. Chichester, UK: Wiley, 1999:261-93.
10. Prescott R. The comparison of success rates in cross-over trials in the presence of an order effect. Appl Stat 1981;30:9-15.
11. Kloner RA, Jarow JP. Erectile dysfunction and sildenafil and cardiologists. Am J Cardiol 1999;83:576-82.